Evidence map›Paper›PMID 29564405›Full record

ReviewJournal of current ophthalmology2018

Orbital invasion of ameloblastoma: A systematic review apropos of a rare entity.

Mohammad-Ali Abtahi, Alireza Zandi, Hassan Razmjoo, Sara Ghaffari, Seyed-Mojtaba Abtahi, Hamidreza Jahanbani-Ardakani, Zahra Kasaei, Samira Kasaei-Koupaei, Sepideh Sajjadi, Seyed-Ali Sonbolestan and 1 more

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of current ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Mohammad-Ali AbtahiIsfahan Eye Research Center, Feiz Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Alireza ZandiIsfahan Eye Research Center, Feiz Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Hassan RazmjooIsfahan Eye Research Center, Feiz Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Sara GhaffariSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Seyed-Mojtaba AbtahiDepartment of Otolaryngology, Head and Neck Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Hamidreza Jahanbani-ArdakaniSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Zahra KasaeiDepartment of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Samira Kasaei-KoupaeiDepartment of Pediatric Dentistry, School of Dentistry, Khorasgan University of Medical Sciences, Isfahan, Iran.
Sepideh SajjadiSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Seyed-Ali SonbolestanIsfahan Eye Research Center, Feiz Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Seyed-Hossein AbtahiIsfahan Eye Research Center, Feiz Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAmeloblastoma is a non-encapsulated and slow-growing tumor with high recurrence rate. Orbital involvement by this neoplasm is an extremely rare entity. In this study, we present a systematic review on this situation along with clinical and paraclinical features of a case.

methodsAn electronic search was conducted on major medical sources. Data of the cases in the literature in addition to our own case were extracted, summarized, and statistically analyzed.

resultsA total of 36 other cases from 20 relevant studies were also reviewed. Review topics included epidemiology, clinical presentation, pathologic features, differential diagnosis, imaging, treatment, and prognosis. We provided a five-year history of a 50-year-old man with orbital/skull base invasion of plexiform maxillary ameloblastoma.

conclusionsMaxillary ameloblastoma is a locally aggressive neoplasm, and physicians must be alert to the biologic behavior of this tumor to detect any invasion to critical structures such as orbit and cranium. Orbital ameloblastoma causes significant morbidity and mortality. We advocate meticulous patient follow-up with regular clinical examinations and paraclinical work-up for timely detection of any invasion or recurrence. The best must be done to avoid extensions by aggressive removal of maxillary ameloblastoma.

Indexed as

AmeloblastomaEyeOrbitReviewVision

Identifiers

PMID29564405
PMCPMC5859465
OpenAlexW2767643924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.